Ward, S.Storey, E.Woods, R.Hamilton, G.Kawasaki, R.Janke, A.Naughton, M.O'Donoghue, F.Wolfe, R.Wong, T.Reid, C.Abhayaratna, W.Stocks, N.Trevaks, R.Fitzgerald, S.Hodgson, L.Robman, L.Workman, B.McNeil, J.2018-04-262018-04-262018Contemporary Clinical Trials, 2018; 64:101-1111551-71441559-2030http://hdl.handle.net/2440/111750Abstract not availableen© 2017 Elsevier Inc. All rights reserved.Sleep disordered breathing; dementia; cognitive decline; low-dose aspirin; brain magnetic resonance imaging; retinal vascular imagingThe Study of Neurocognitive Outcomes, Radiological and Retinal Effects of Aspirin in Sleep Apnoea- rationale and methodology of the SNORE-ASA studyJournal article003007708710.1016/j.cct.2017.10.0160004236472000142-s2.0-85032961681386764Stocks, N. [0000-0002-9018-0361]